Skip to main content

Table 1 Patients’ characteristics

From: Outcome of ductus arteriosus stenting including vertical tubular and convoluted tortuous ducts with emphasis on technical considerations

Patients’ demographics

 Age (days), median (range)

18 (1–2190)

 Weight (kg), median (range)

3.1 (2.1–13)

 Male/female, n (%)

25 (58.1)/18 (41.9)

 Full term/preterm n (%)

38 (88.4)/5(11.6)

Diagnosis

 Pulmonary atresia/ventricular septal defect, n (%)

12 (27.9)

 Pulmonary atresia/intact interventricular septum, n (%)

9 (20.9)

 Pulmonary atresia/tricuspid atresia, n (%)

6 (13.9)

 Complex congenital heart disease, n (%)

6 (13.9)

 TGA-VSD-pulmonary stenosis, n (%)

4 (9.3)

 Pulmonary atresia with a complete atrioventricular septal defect, n (%)

3 (6.7)

 Pulmonary atresia with Ebstein anomaly, n (%)

2 (4.6)

 Critical pulmonary stenosis, n (%)

1 (2.3)

Angiography

 Aortic arch sidedness, n (%)

  Left

30 (69.8)

  Right

13 (30.2)

 PDA length/diameter

  Diameter (mm), median (range)

2.4 (0.8–3.9)

  Length (mm), median (range)

17.3 (9–35)

 PDA origin, n (%)

  Origin from the undersurface of the aortic arch

16 (37.2)

  Origin from proximal descending aorta

14 (32.5)

  Origin from intermediate position

3 (6.7)

  Origin from the subclavian or brachiocephalic artery (3 patients had double PDAs)

10 (23.2)

 PDA morphology, n (%)

  Tortuous

23 (53.5)

  Long tubular

12 (27.9)

  Conical

8 (18.6)

  1. PDA patent ductus arteriosus, VSD ventricular septal defect, TGA transposition of great arteries